The commissioning of lisdexamfetamine is accepted in Devon for the management of attention deficit hyperactivity disorder (ADHD) in children aged 6 years of age and over for whom previous drug treatment for ADHD, including methylphenidate, has been unsatisfactory.
Please note there is a separate policy for lisdexamfetamine for ADHD in adults.
| Filename: | Lisdexamfetamine for the management of attention deficit hyperactivity disorder (ADHD) in children and adolescents |
| Filetype: | |
| Filesize: | 92.51 KB |
| Date uploaded: | 13th April 2016 |
| Date updated: | 8th December 2022 |
